
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Cycloserine
Therapeutic Area : Psychiatry/Psychology
Study Phase : Phase II/ Phase III
Recipient : NRx Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Cycloserine is a small molecule drug candidate, which is currently being evaluated in Phase II/ Phase III clinical studies for the treatment of Depressive Disorder, Treatment-Resistant.
Product Name : Undisclosed
Product Type : Antibiotic
Upfront Cash : Inapplicable
November 12, 2025
Lead Product(s) : Cycloserine
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Phase II/ Phase III
Recipient : NRx Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable
